Omer S Karrar

11PUBLICATIONS
55CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virologyCancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 16, 2026
Predictors of survival in adults with B-cell acute lymphoblastic leukemia treated with blinatumomab and/or inotuzumab ozogamicin in first salvage.

|Jun 01, 2026
Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: implications for the optimal frequency of MRD monitoring.

|May 27, 2026
Long-Term Outcomes of Azacitidine, Venetoclax and Gilteritinib in Newly Diagnosed FLT3-Mutated AML.

|Feb 06, 2026
Prospective feasibility study of peripheral blood for MRD detection in acute myeloid leukemia by flow cytometry.

Shaoying Li, Nicholas J Short, Wei Wang

|Sep 02, 2025
Cytomolecular Mechanisms of Relapse and Post-Relapse Outcomes After Frontline FLT3 Inhibitor-Based Therapy in FLT3 -Mutated AML.

Sankalp Arora, Sanam Loghavi, Naval Daver

|Aug 09, 2025
Outcomes and patterns of relapse with ponatinib-based therapy in patients with chronic myeloid leukemia in myeloid blast phase.

Omer Karrar, Hagop Kantarjian, Fadi G Haddad

Pageof 2

Frequent Collaborators

6 joint publications

Nicholas J Short

4 joint publications

Naseema Gangat

4 joint publications

Aref Al-Kali

4 joint publications

Kebede H Begna